Table 4.
Univariate and multivariate analyses for OS and PFS
Univariate analysis | Multivariate analysis | |||||||
---|---|---|---|---|---|---|---|---|
OS | PFS | OS | PFS | |||||
HR(95%CI) | p-value | HR(95%CI) | p-value | HR(95%CI) | p-value | HR(95%CI) | p-value | |
Age | 1.033 (0.988–1.080) | 0.155 | 1.001 (0.969–1.035) | 0.931 | ||||
Grade 1 vs. grade 2,3 | 3.566 (0.474–26.854) | 0.217 | 1.862 (0.570–6.080) | 0.303 | ||||
Stage | 1.946 (1.096–3.455) | 0.023 | 2.092 (1.385–3.161) | 0.000 | 1.877 (1.154–3.052) | 0.011 | ||
Serous vs. other histopathology | 1.114 (0.452–2.745) | 0.814 | 0.815 (0.417–1.595) | 0.550 | ||||
HE4-median pretreatment | 1.893 (0.744–4.815) | 0.181 | 2.325 (1.157–4.673) | 0.018 | 2.315 (1.084–4.941) | 0.030 | ||
HE4-clearance after 3rd cycle of chemotherapy | 8.295 (2.984–23.057) | 0.000 | 3.632 (1.877–7.027) | 0.000 | 8.294 (2.980–23.085) | 0.000 | 2.713 (1.361–5.407) | 0.005 |
CA125-median pretreatment | 0.645 (0.259–1.606) | 0.346 | 0.878 (0.456–1.690) | 0.697 | ||||
CA125-clearance after 1st cycle of chemotherapy | 2.556 (1.4027–6.361) | 0.044 | 2.435 (1.260–4.709) | 0.008 | 2.549 (1.019–6.378) | 0.045 | 3.853 (1.888–7.865) | 0.000 |